Vyome Holdings, Inc (HIND): Gross Profit
$218.8K
Year ended 2025-12-31
-68.2%
3-year compound annual growth
-48.9%
5-year compound annual growth
-17.7%
10-year compound annual growth
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $218.8K | +12.2% | 2026-03-18, From 2025-01-01 |
| 2024-12-31 | $195.0K | -96.5% | 2026-03-18, From 2024-01-01 |
| 2023-12-31 | $5.55M | -18.4% | 2025-04-04, From 2023-01-01 |
| 2022-12-31 | $6.80M | -18.5% | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | $8.35M | +33.3% | 2023-04-17, From 2021-01-01 |
| 2020-12-31 | $6.26M | n/m | 2022-04-08, From 2020-01-01 |
| 2019-12-31 | $331.0K | -91.0% | 2021-03-12, From 2019-01-01 |
| 2018-12-31 | $3.68M | -27.7% | 2020-02-27, From 2018-01-01 |
| 2017-12-31 | $5.08M | +770.7% | 2019-02-22, From 2017-01-01 |
| 2016-12-31 | $584.0K | -62.0% | 2018-03-05, From 2016-01-01 |
| 2015-12-31 | $1.54M | +145.0% | 2018-03-05, From 2015-01-01 |
| 2014-12-31 | $627.0K | n/a | 2017-02-23, From 2014-01-01 |
Gross Profit at similar companies
| Company | Year ended | Gross Profit | Change YoY |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | 2025-12-31 | $218.8K | +12.2% |
| Abvc Biopharma, Inc. (ABVC) | 2024-12-31 | $508.8K | n/m |
| Scienture Holdings, Inc. (SCNX) | 2025-12-31 | $331.5K | n/m |
| Clene Inc. (CLNN) | 2025-12-31 | $157.0K | -42.3% |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | $389.8K | -32.2% |
| Silence Therapeutics plc (SLN) | 2025-12-31 | $344.0K | -98.9% |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | $185.3K | n/a |
| BioXcel Therapeutics, Inc. (BTAIQ) | 2025-12-31 | $478.0K | +288.6% |
| Polomar Health Services, Inc. (PMHS) | 2025-12-31 | $460.1K | n/m |
Compare HIND, ABVC, SCNX, CLNN side by side · Screen every company in Pharmaceutical Preparations ↗